Conley J, Genenger B, Ashford B, Ranson M
Int J Mol Sci. 2024; 25(15).
PMID: 39126067
PMC: 11313315.
DOI: 10.3390/ijms25158493.
Ota S, Yokoyama K, Kanamori F, Mamiya T, Uda K, Araki Y
Acta Neurochir (Wien). 2023; 165(8):2045-2055.
PMID: 37079107
DOI: 10.1007/s00701-023-05579-6.
Liu F, Li S
Front Pharmacol. 2022; 13:934396.
PMID: 36034860
PMC: 9399465.
DOI: 10.3389/fphar.2022.934396.
Daneluzzi C, Seyed Jafari S, Hunger R, Bossart S
J Clin Med. 2022; 11(15).
PMID: 35956111
PMC: 9370013.
DOI: 10.3390/jcm11154494.
Fontemaggi G
IUBMB Life. 2022; 75(1):30-39.
PMID: 35467790
PMC: 10084289.
DOI: 10.1002/iub.2620.
Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?.
Tamas T, Baciut M, Nutu A, Bran S, Armencea G, Stoia S
Genes (Basel). 2021; 12(12).
PMID: 34946878
PMC: 8701953.
DOI: 10.3390/genes12121929.
MicroRNA-361 reduces the viability and migratory ability of pancreatic cancer cells via mediation of the MAPK/JNK pathway.
Wang J, Xie Z, Liu Y, Zhang W, Ji T
Exp Ther Med. 2021; 22(6):1365.
PMID: 34659511
PMC: 8515516.
DOI: 10.3892/etm.2021.10799.
MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway.
Jiang S, Liu H, Zhang J, Zhang F, Fan J, Liu Y
Cancer Biol Ther. 2021; 22(5-6):381-391.
PMID: 34369270
PMC: 8386739.
DOI: 10.1080/15384047.2021.1941583.
Competing Endogenous RNA Networks in Glioma.
Cen L, Liu R, Liu W, Li Q, Cui H
Front Genet. 2021; 12:675498.
PMID: 33995499
PMC: 8117106.
DOI: 10.3389/fgene.2021.675498.
Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer-Search for Non-Invasive Diagnostic Biomarkers.
Kryczka J, Migdalska-Sek M, Kordiak J, Kiszalkiewicz J, Pastuszak-Lewandoska D, Antczak A
Diagnostics (Basel). 2021; 11(3).
PMID: 33802346
PMC: 7998231.
DOI: 10.3390/diagnostics11030425.
miR-361-5p regulates ovarian cancer cell proliferation and apoptosis by targeting TRAF3.
Ling J, He P
Exp Ther Med. 2021; 21(3):199.
PMID: 33500694
PMC: 7818538.
DOI: 10.3892/etm.2021.9632.
microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Ma X, Wu D, Zhang X, Shao X, Hu G
Technol Cancer Res Treat. 2020; 19:1533033820980098.
PMID: 33280526
PMC: 7724270.
DOI: 10.1177/1533033820980098.
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations.
Martinez B, Peplow P
Neural Regen Res. 2020; 16(3):440-447.
PMID: 32985463
PMC: 7996036.
DOI: 10.4103/1673-5374.293131.
The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell Carcinoma.
Garofoli M, Volpicella M, Guida M, Porcelli L, Azzariti A
Cancers (Basel). 2020; 12(9).
PMID: 32911687
PMC: 7565940.
DOI: 10.3390/cancers12092552.
miR-361-5p Mediates SMAD4 to Promote Porcine Granulosa Cell Apoptosis through VEGFA.
Ma M, Zhang J, Gao X, Yao W, Li Q, Pan Z
Biomolecules. 2020; 10(9).
PMID: 32899767
PMC: 7563248.
DOI: 10.3390/biom10091281.
CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells.
Long N, Chu L, Jia J, Peng S, Gao Y, Yang H
Cancer Cell Int. 2020; 20:374.
PMID: 32774168
PMC: 7409503.
DOI: 10.1186/s12935-020-01454-x.
Long noncoding RNA MALAT1 promotes high glucose-induced inflammation and apoptosis of vascular endothelial cells by regulating miR-361-3p/SOCS3 axis.
Huang K, Yu X, Yu Y, Zhang L, Cen Y, Chu J
Int J Clin Exp Pathol. 2020; 13(5):1243-1252.
PMID: 32509100
PMC: 7270668.
MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
Xu D, Dong P, Xiong Y, Yue J, Konno Y, Ihira K
Cells. 2020; 9(3).
PMID: 32151082
PMC: 7140536.
DOI: 10.3390/cells9030632.
MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling.
Ma J, Jing X, Chen Z, Duan Z, Zhang Y
Int J Clin Exp Pathol. 2020; 11(5):2588-2596.
PMID: 31938372
PMC: 6958233.
Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome.
Sorensen A, Udesen P, Maciag G, Geiger J, Saliani N, Januszewski A
Front Med (Lausanne). 2019; 6:242.
PMID: 31737638
PMC: 6839444.
DOI: 10.3389/fmed.2019.00242.